Apr 19, 2024 04:01 PM
Shukra Pharmaceuticals Ltd
SECTOR : Pharmaceuticals | BSE :524632 |
CLIENT NAME | DEAL TYPE | ACTION | DATE | AVG. PRICE | QUANTITY | EXCHANGE |
---|
Financials( ₹ in Cr) | Shukra Pharmaceuticals Ltd | Sun Pharmaceuticals Industries Ltd | Cipla Ltd | Dr Reddys Laboratories Ltd | Divis Laboratories Ltd |
---|---|---|---|---|---|
Price | 84.75 | 1,522.80 | 1,345.75 | 5,942.85 | 3,671.70 |
% Change | -74.50 | 0.42 | -0.12 | -0.24 | -1 |
Mcap ₹ Cr | 92.78 | 365,370.73 | 108,649.13 | 99,132.09 | 97,472.25 |
Revenue TTM ₹ Cr | 58.83 | 43,885.68 | 15,790.60 | 24,669.70 | 7,767.51 |
Net Profit TTM ₹ Cr | 4.41 | 8,560.84 | 2,513.47 | 4,507.30 | 1,823.38 |
PE TTM | 19.63 | 38.80 | 27.51 | 19.01 | 71.35 |
1 Year Return | 29.91 | 51.55 | 45.60 | 20.98 | 12.26 |
ROCE | 18.84 | 16.79 | 14.76 | 25.99 | 19.30 |
ROE | 21.18 | 16.46 | 10.66 | 21.21 | 14.89 |
Equity Capital: 25.29 Cr FV: 10.00
Period | MF Net Purchase / (sold) | FII Net |
---|---|---|
LAST 1M | 26,468.76 | -11,822.98 |
LAST 3M | 81,914.65 | 34,986.47 |
LAST 6M | 142,142.07 | 66,572.41 |
LAST 12M | 217,201.91 | 193,346.69 |
Date | Action Type | Ratio |
---|---|---|
Apr 19, 2024 | Bonus | 3:1 |
Sep 15, 2023 | Dividend | 5 |
Sep 22, 2022 | Dividend | 5 |
Shukra Pharmaceuticals Ltd (Formerly known Relish Pharmaceuticals Limited) was established in March 1993 and later on the name of Company got changed from Relish Pharmaceuticals Limited to Shukra Pharmaceuticals Limited effective on 22 September, 2016. The Company is presently engaged in the business of manufacturing of pharmaceuticals Products and laboratory testing. The company provides varieties of products to the clientele. Their product portfolio includes Antibiotics (Penicillin), Anti Biotics (Cephalosporin), Anti Biotics, Macrolides, Quinolones, Anti Bacterial, Anti Fungal, Anti Malarial, Anti Viral, Anti Protozoal, Anti Anthelmintic, Sedative and Tranquilliser, Anti Depressant, Anti Manic, Anti Emetic, Anti Ulcer, Beta Blockers, Diuretics, Analgesic, Analgesic (NASID), Muscle Relaxants, Anti Tuberculosis, Vitamin Products, Anti Allergics, Corticosteroids, Hyper and Hypoglycemic, Others. The company has four manufacturing divisions namely tablets (General and Beta Lactum) Capsules (General and Beta Lactum), Liquid and small volume parental. Their manufacturing unit is located at Rakanpur in Gujarat. The company customers include leading Manufacturers like Cadila Healthcare Limited (Zydus), Intas Pharmaceuticals Limited, Cadila Pharmaceuticals Limited, Makers Laboratories Limited, Agenta Pharma Limited etc. The company has assisted in the development and manufacture of a wide variety of drugs and dosage forms and potency variations for many prestigious pharmaceuticals companies around the world. In FY 2013-14, the Company got approval from Hon`ble High Court of Gujarat for revival of Relish Pharmaceuticals Limited and Amalgamation of Proper Dealcomm Private Limited (Transferor Company) with Relish Pharmaceuticals Limited (Transferee Company) and Re-organization of Share Capital of Relish Pharmaceuticals Limited (Transferee Company) through Scheme of Arrangement vide Hon`ble High Court of Gujarat order dated 20 Dec` 2013.
3 rd Floor Dev House, Opp WIAA Office Judges Bungalo, Ahmedabad, Gujarat, 380054
Tel | : | 91-079-66522247/27498515 |
: | info:shukrapharmaceuticals.com | |
Website | : | http://www.shukrapharmaceuticals.com |
Sharepro Services
AGM Date (Month) | : | Sep |
Face Value Equity Shares | : | 10 |
Market Lot Equity Shares | : | 1 |
BSE Code | : | 524632 |
NSE Code | : | |
Book Closure Date (Month) | : | Sep |
BSE Group | : | X |
ISIN | : | INE551C01028 |
You can buy Shukra Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Shukra Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of Apr 19, 2024 04:01 PM the closing price of Shukra Pharmaceuticals Ltd was ₹ 84.75.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of Apr 19, 2024 04:01 PM, the market cap of Shukra Pharmaceuticals Ltd stood at ₹ 92.78.
The latest PE ratio of Shukra Pharmaceuticals Ltd as of Apr 19, 2024 04:01 PM is 19.63
The latest PB ratio of Shukra Pharmaceuticals Ltd as of Apr 19, 2024 04:01 PM is 0.12
The 52-week high of Shukra Pharmaceuticals Ltd share price is ₹ 388.00 while the 52-week low is ₹ 68.50